AcelRx Pharmaceuticals Inc (NASDAQ:ACRX)

4.05
Delayed Data
As of Jun 21
 +0.05 / +1.25%
Today’s Change
1.55
Today|||52-Week Range
5.75
+100.00%
Year-to-Date
Small Drugmakers Edging Out the Bigshots: 7 Stocks to Buy
Jun 19 / Zacks.com - Paid Partner Content
Top Ranked Momentum Stocks to Buy for June 8th
Jun 08 / Zacks.com - Paid Partner Content
Top Ranked Momentum Stocks to Buy for June 15th
Jun 15 / Zacks.com - Paid Partner Content
 

Today’s Trading

Previous close4.00
Today’s open4.00
Day’s range3.95 - 4.20
Volume698,260
Average volume (3 months)548,494
Market cap$130.9M
Data as of 4:00pm ET, 06/21/2018

Growth & Valuation

Earnings growth (last year)-15.79%
Earnings growth (this year)+16.97%
Earnings growth (next 5 years)+46.60%
Revenue growth (last year)-53.94%
P/E ratioNM
Price/Sales11.87
Price/Book--

Competitors

 Today’s
change
Today’s
% change
CDMOAvid Bioservices Inc-0.07-2.10%
MLNTMelinta Therapeutics...-0.50-6.29%
RDHLRedhill Biopharma Lt...-0.33-4.04%
TRVNTrevena Inc-0.03-1.76%
Data as of 4:00pm ET, 06/21/2018

Financials

Next reporting dateAugust 13, 2018
EPS forecast (this quarter)-$0.21
Annual revenue (last year)$8.0M
Annual profit (last year)-$51.5M
Net profit margin-644.25%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
Independent Director
Stephen J. Hoffman
Chief Executive Officer &
Director
Vincent J. Angotti
Corporate headquarters
Redwood City, California

Forecasts